Innate Immunity
Part of Vaccines
The body’s immediate, non-specific defense system that responds instantly to any foreign threat.
Why This Matters
Every vaccine, no matter how sophisticated, must activate the innate immune system to work. Without an innate danger signal, the adaptive immune system remains quiet even in the presence of foreign antigens. Understanding innate immunity explains why some vaccine formulations work and others don’t, why adjuvants are necessary for killed vaccines, and why live vaccines generally produce stronger responses.
Innate immunity is also the body’s first line of defense during the window between vaccination and full adaptive immunity developing — the days to weeks when the adaptive system is building its response. A healthy innate immune system limits initial pathogen growth during this window, buying time for specific immunity to activate.
Beyond vaccine science, understanding innate immunity guides practical clinical decisions: why fever is often beneficial, why inflammatory responses should not always be suppressed, and how the body’s natural defenses interact with medical interventions.
Physical and Chemical Barriers
The first component of innate immunity never involves immune cells at all — it is the body’s architectural exclusion of pathogens.
Skin: The skin is an extraordinary barrier. Cornified (keratinized) cells create a mechanically tough, waterproof surface impenetrable to most pathogens. Desquamation (constant skin cell shedding) removes surface organisms before they can establish infection. Sebaceous secretions create an acidic, fatty acid-rich environment hostile to bacterial growth.
When skin is broken — by wound, injection, or abrasion — this barrier is breached. Every injection in medical practice represents a calculated acceptance of this risk.
Mucous membranes: Respiratory, gastrointestinal, and urogenital tracts are lined with mucous membranes — epithelial surfaces covered in mucus. Mucus traps pathogens; cilia (hair-like projections) sweep mucus and trapped organisms upward for expectoration or swallowing. Mucus contains antimicrobial proteins: lysozyme (destroys bacterial cell walls), lactoferrin (sequesters iron, limiting bacterial growth), defensins (membrane-disrupting peptides).
Stomach acid: Gastric acid (pH 1.5-3.5) kills most pathogens that are swallowed. This is why cholera requires a very high infective dose when ingested (10⁶-10⁸ organisms) compared to Shigella, which is acid-resistant and infective at very low doses (10-100 organisms).
Cellular Innate Immunity
Phagocytes: Professional Killers
Neutrophils: Short-lived (hours to days) first responders. Circulate in blood and are recruited to sites of infection within minutes. Engulf bacteria through phagocytosis and kill them using reactive oxygen species, proteases, and defensins in the phagolysosome. Also release toxic contents extracellularly (NET — neutrophil extracellular traps) to kill large pathogens.
Neutrophil-dominated inflammation appears as pus — the exudate of dead neutrophils and killed bacteria is clinically useful for identifying bacterial infection.
Macrophages: Longer-lived (months to years) phagocytes residing in tissues. Multiple functions:
- Phagocytose and kill bacteria, fungi, and dead cells
- Present antigens to adaptive immune cells (link innate to adaptive immunity)
- Release cytokines that coordinate immune response
- Respond to activation signals from T cells (enhanced killing of intracellular organisms)
Macrophages in different tissues have different names: Kupffer cells (liver), microglia (brain), alveolar macrophages (lungs), but share core functions.
Dendritic cells: Key bridge between innate and adaptive immunity. Patrol tissues, engulf foreign material, migrate to lymph nodes, and present antigens to T cells. Their cytokine environment during antigen presentation determines what type of T cell response develops.
Pattern Recognition
Innate immune cells recognize pathogens through pattern recognition receptors (PRRs) that detect pathogen-associated molecular patterns (PAMPs) — molecular structures common to many pathogens but absent from human cells.
Key PAMPs and their receptors:
| PAMP | Source | Receptor |
|---|---|---|
| Lipopolysaccharide (LPS) | Gram-negative bacteria cell wall | TLR4 |
| Peptidoglycan | Gram-positive bacteria | TLR2 |
| Flagellin | Bacterial flagella | TLR5 |
| Double-stranded RNA | Viruses during replication | TLR3 |
| Unmethylated CpG DNA | Bacteria and viruses | TLR9 |
When PRRs detect PAMPs, they trigger inflammatory signaling cascades (NF-κB pathway) that produce cytokines, upregulate antimicrobial defenses, and activate dendritic cells — launching both immediate defense and adaptive immune activation.
Relevance to adjuvants: Many vaccine adjuvants work by stimulating these same pattern recognition receptors. Alum activates the NLRP3 inflammasome. LPS derivatives activate TLR4. CpG oligonucleotides activate TLR9. This explains why adjuvants cause the injection-site inflammation they do — they are intentionally mimicking bacterial danger signals to activate innate immunity and drive adaptive response.
Inflammatory Response
Inflammation is the coordinated local response to tissue damage or infection. It is not a malfunction — it is a precisely regulated defense.
Cardinal signs of inflammation:
- Rubor (redness): vasodilation brings more blood
- Calor (heat): increased metabolism and blood flow
- Tumor (swelling): plasma proteins and cells exit blood vessels
- Dolor (pain): sensitization of nociceptors
- Functio laesa (loss of function): protects damaged area
Key inflammatory mediators:
Histamine: Released by mast cells immediately on injury. Causes vasodilation and increased vascular permeability (the first minutes of acute inflammation).
Prostaglandins: Lipid mediators produced by many cells. Cause fever, pain sensitization, vasodilation. Aspirin and willow bark (salicylate) inhibit prostaglandin synthesis — hence anti-fever and anti-pain effects.
Cytokines (IL-1, IL-6, TNF-α): Small signaling proteins released by macrophages after PRR activation. Key effects:
- Fever: act on hypothalamus to raise temperature set-point
- Acute phase response: liver produces C-reactive protein, fibrinogen, other immune proteins
- Bone marrow stimulation: increased neutrophil production
- Fatigue, muscle aching: systemic effects of systemic inflammation
Why fever is beneficial: Temperature elevation:
- Inhibits bacterial growth (many pathogens are temperature-sensitive)
- Accelerates immune cell activity
- Enhances antibody production
- Increases neutrophil and macrophage killing efficiency
Fever up to 39°C in a healthy adult is protective. Extreme fever (>41°C) can cause harm. The instinct to suppress moderate fever with willow bark or other antipyretics may slow immune response — this is worth considering clinically.
Natural Killer Cells
Natural killer (NK) cells occupy a unique niche: they kill infected or cancerous cells without requiring prior sensitization (unlike cytotoxic T cells, which must be specifically activated).
NK cells monitor surface markers on all cells they contact. Healthy normal cells express a surface protein (MHC class I) that signals NK cells to leave them alone. Virally infected cells and cancer cells often downregulate MHC class I expression — missing self — and are targeted for killing by NK cells.
NK cells also kill cells coated with antibodies (antibody-dependent cellular cytotoxicity, ADCC) — another link between innate and adaptive immunity.
Role in vaccine response: NK cells contribute to early control of viral infection in the days before specific T cell responses are active. Vaccines that activate strong innate responses may also activate NK cells, providing earlier partial protection.
Complement System
The complement system is a set of ~20 serum proteins that work in a cascade to:
- Directly lyse bacterial membranes (membrane attack complex)
- Tag pathogens for phagocytosis (opsonization via C3b deposition)
- Attract phagocytes to sites of infection (chemotaxis via C5a)
- Enhance B cell activation (via C3d)
Complement can be activated three ways:
- Classical pathway: Triggered by antibody-antigen complexes — requires adaptive immunity
- Alternative pathway: Triggered directly by pathogen surfaces — no antibody needed
- Lectin pathway: Triggered by mannose-binding lectin recognizing mannose on pathogen surfaces
The alternative and lectin pathways represent innate complement activation — immediate, antigen-specific, and effective against bacteria even before any specific immune response has developed.
Practical Implications for Practitioners
Support the innate response:
- Do not suppress mild fever (up to 39°C) in vaccine recipients or infected patients unless causing distress
- Ensure adequate nutrition — malnourished individuals have impaired innate immunity, particularly reduced neutrophil function
- Treat wounds promptly — infection through broken barriers overwhelms innate defenses
Recognize innate response limits:
- Innate immunity alone cannot control most pathogens beyond 3-5 days without adaptive support
- Septic shock (overwhelming systemic inflammation) represents innate immunity overwhelming normal regulation — a medical emergency
Vaccine formulation decisions:
- Killed vaccines without adjuvants may fail to activate innate immunity sufficiently → add adjuvant
- Live vaccines replicate and produce PAMPs → innate activation built in
- Injection site inflammation after vaccination is innate activation — expected and beneficial, not a failure